A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase (Q36738836)
Jump to navigation
Jump to search
scientific article published on 22 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase |
scientific article published on 22 November 2015 |
Statements
1 reference
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase (English)
1 reference
Nandini Sakurikar
1 reference
Ruth Thompson
1 reference
Ryan Montano
1 reference
Alan Eastman
1 reference
22 November 2015
1 reference
1 reference
1380-1394
1 reference
Identifiers
1 reference
1 reference
1 reference